446 related articles for article (PubMed ID: 34156647)
21. Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients.
Kovacevic T; Miljkovic B; Kovacevic P; Dragic S; Momcicevic D; Avram S; Jovanovic M; Vucicevic K
J Crit Care; 2020 Feb; 55():116-121. PubMed ID: 31715528
[TBL] [Abstract][Full Text] [Related]
22. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.
Hartman SJF; Brüggemann RJ; Orriëns L; Dia N; Schreuder MF; de Wildt SN
Clin Pharmacokinet; 2020 Feb; 59(2):173-205. PubMed ID: 31432468
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review.
Akunne OO; Mugabo P; Argent AC
Eur J Drug Metab Pharmacokinet; 2022 Jan; 47(1):31-48. PubMed ID: 34750740
[TBL] [Abstract][Full Text] [Related]
25. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
[TBL] [Abstract][Full Text] [Related]
26. Improved vancomycin dosing in children using area under the curve exposure.
Le J; Bradley JS; Murray W; Romanowski GL; Tran TT; Nguyen N; Cho S; Natale S; Bui I; Tran TM; Capparelli EV
Pediatr Infect Dis J; 2013 Apr; 32(4):e155-63. PubMed ID: 23340565
[TBL] [Abstract][Full Text] [Related]
27. Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?
Heffernan AJ; Germano A; Sime FB; Roberts JA; Kimura E
Eur J Clin Pharmacol; 2019 Sep; 75(9):1219-1226. PubMed ID: 31154476
[TBL] [Abstract][Full Text] [Related]
28. Population Pharmacokinetics and Pharmacodynamics of Norvancomycin in Children With Malignant Hematological Disease.
Wang J; Li SC; Ye Q; Gao LL; Nie YM; Xu H; Wu M; Cao P; Wang Y
J Clin Pharmacol; 2020 Sep; 60(9):1220-1230. PubMed ID: 32488878
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic monitoring of intravenous vancomycin in a pediatric critical care unit].
Villena R; González CA; Nalegach ME; Vásquez A; Villareal M; Drago M
Rev Chilena Infectol; 2014 Jun; 31(3):249-53. PubMed ID: 25146197
[TBL] [Abstract][Full Text] [Related]
30. Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease.
Zhao W; Zhang D; Fakhoury M; Fahd M; Duquesne F; Storme T; Baruchel A; Jacqz-Aigrain E
Antimicrob Agents Chemother; 2014 Jun; 58(6):3191-9. PubMed ID: 24663023
[TBL] [Abstract][Full Text] [Related]
31. Population Pharmacokinetics and Dosing Optimization of Vancomycin in Infants, Children, and Adolescents with Augmented Renal Clearance.
He CY; Ye PP; Liu B; Song L; van den Anker J; Zhao W
Antimicrob Agents Chemother; 2021 Sep; 65(10):e0089721. PubMed ID: 34339268
[TBL] [Abstract][Full Text] [Related]
32. Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.
Avedissian SN; Bradley E; Zhang D; Bradley JS; Nazer LH; Tran TM; Nguyen A; Le J
Pediatr Crit Care Med; 2017 Sep; 18(9):e388-e394. PubMed ID: 28640009
[TBL] [Abstract][Full Text] [Related]
33. Changes in vancomycin pharmacokinetics in critically ill infants.
Gous AG; Dance MD; Lipman J; Luyt DK; Mathivha R; Scribante J
Anaesth Intensive Care; 1995 Dec; 23(6):678-82. PubMed ID: 8669599
[TBL] [Abstract][Full Text] [Related]
34. Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients.
Zakova M; Pong S; Trope A; Atenafu EG; Papaioannou V; Bitnun SA; Richardson S; Schwartz S; Cox P; Parshuram C; Seto W
Ther Drug Monit; 2014 Jun; 36(3):288-94. PubMed ID: 24695354
[TBL] [Abstract][Full Text] [Related]
35. Vancomycin dosing in critically ill trauma patients: The VANCTIC Study.
Villanueva RD; Talledo O; Neely S; White B; Celii A; Cross A; Kennedy R
J Trauma Acute Care Surg; 2019 Nov; 87(5):1164-1171. PubMed ID: 31464871
[TBL] [Abstract][Full Text] [Related]
36. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
[TBL] [Abstract][Full Text] [Related]
37. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG
Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677
[TBL] [Abstract][Full Text] [Related]
38. Evaluation and Development of Vancomycin Dosing Schemes to Meet New AUC/MIC Targets in Intermittent Hemodialysis Using Monte Carlo Simulation Techniques.
Lewis SJ; Mueller BA
J Clin Pharmacol; 2021 Feb; 61(2):211-223. PubMed ID: 32851685
[TBL] [Abstract][Full Text] [Related]
39. Vancomycin dosing in children and young adults: back to the drawing board.
Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
[TBL] [Abstract][Full Text] [Related]
40. Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children.
Nichols K; Chung EK; Knoderer CA; Buenger LE; Healy DP; Dees J; Crumby AS; Kays MB
Antimicrob Agents Chemother; 2016 Jan; 60(1):522-31. PubMed ID: 26552978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
